NCT00389298View on ClinicalTrials.gov

A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

June 30, 2007

Conditions
Hepatitis C, Chronic
Interventions
DRUG

VCH-759 (BCH-27759)

Trial Locations (4)

T2N 4N1

Foothills Medical Centre, Calgary

V5Z 1H2

Liver and Intestinal Research Centre, Vancouver

K1H 8L6

Ottawa Hospital; General Campus, Ottawa

H3A 1A1

McGill University Hospital Centre (MUHC) - Royal Victoria Hospital, Montreal

All Listed Sponsors
collaborator

ViroChem Pharma

INDUSTRY

lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT00389298 - A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection. | Biotech Hunter | Biotech Hunter